Article: Nicotinamide Riboside Supplementation Supports Immune Regulation in Human Cells and Blood: Clinical Findings

Clinical Immune Health

Nicotinamide Riboside Supplementation Supports Immune Regulation in Human Cells and Blood: Clinical Findings

Objectives

To investigate how NR influences the migration of macrophages and the underlying mechanisms behind this effect.

Journal

Cells

Key Outcomes

Ex Vivo:

NR treatment increased levels of NAD+ and prostaglandin E2 (PGE2), a key regulator of inflammatory and immune responses, in monocytes from healthy subjects.

In Vivo:

NR supplementation increased PGE2 levels in human serum.

Duration

1 week

Dose

1000 mg

Study Design

Ex Vivo:
Monocytes were extracted from young, healthy subjects and then treated with NR

In Vivo:
Randomized, double-blind, placebo-controlled, pilot study in 36 young, healthy subjects

See Published Study

Clinical

Nicotinamide Riboside and CoQ10 Supplementation May Support Kidney Health in Chronic Kidney Disease: Clinical Findings

Objectives To examine the effects of NR and coenzyme Q10 (CoQ10) supplementation alone for six weeks on physical endurance, work efficiency, and metabolic profile in chronic kidney disease (CKD) p...

Cardiovascular Disease

Nicotinamide Riboside Supplementation Enhances Walking Performance in Peripheral Artery Disease: Clinical Findings

Objectives To assess the effects of NR supplementation alone and in combination with resveratrol on the six-minute walk distance in individuals with peripheral artery disease (PAD). Journal Natur...